We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Rapid POC Salivary Diagnostic Technology Shows Potential for Detecting Various Disease Biomarkers

By LabMedica International staff writers
Posted on 15 May 2023

Across the globe, approximately 3. More...

5 billion individuals are currently afflicted by oral diseases. Numerous oral bacteria are also associated with systemic illnesses such as diabetes, heart disease, and cancer. Now, a new diagnostic tool that can be used in a dental office analyzes saliva samples to provide comprehensive information on oral health and determine the risk for cavities and gum disease and systemic diseases.

Scientists from the Forsyth Institute (Cambridge, MA, USA) have demonstrated a CRISPR-based technology that can identify specific oral pathogens in approximately half an hour. The SHERLOCK system, a CRISPR-Cas molecular diagnostic platform, can accurately pinpoint and target RNA and DNA molecules in a sequence-specific manner. This technology has been tailored to target four oral bacteria known to contribute to oral health issues, such as periodontitis (gum disease) and dental cavities. The new point-of-care diagnostic technology could revolutionize dental care and facilitate early disease detection, eliminating the discomfort, inconvenience, and expense of blood tests.

In the recent study, the researchers tested the system on three bacteria associated with a variety of conditions, including cancer, digestive diseases, cardiovascular diseases, and neurodegenerative diseases. The findings indicated the impressive adaptability of the diagnostic tool to identify any biomarker from saliva, including markers related to inflammation and cancer. Using this innovative detection method, a person could simply provide a saliva sample and receive highly precise results in a minimal amount of time. This test could be administered in a dental clinic without the need for specialized skills.

“Targeted treatments are only possible when you know which bugs are in the mouth. In any disease, we cannot begin to create effective treatments until we have diagnostics,” said Dr. Batbileg Bor, who led the study and is an Assistant Member of Staff at Forsyth. “Currently, available tests on the market are either low sensitivity or require analysis at an expensive centralized laboratory. It can take months to get the results. The studied detection tool solves both problems, featuring high-sensitivity, low-cost tests with rapid results.”

“The test is so sensitive it can detect as little as 10s of bacteria cells of a certain type from a sample that might contain around 200 species of bacteria commonly found in your mouth,” added Dr. Bor. “We were able to target and detect specific bacteria in unprocessed saliva, meaning we could get this level of sensitivity and specificity without having to additionally process the saliva sample.”

Related Links:
Forsyth Institute 


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.